VCAM1 and acute lymphoblastic leukemia: Furthermore, VCAM-1 over-expression in stromal cell lines enhanced B-ALL resistance to chemotherapeutic drugs in vitro while VLA-4 negative variants of the B-ALL cell line Nalm6 had a decreased capacity to engraft in immunodeficient mice (56, 57).